Key facts: Hims & Hers Health shares drop 14.1%; FDA restricts weight-loss pill

TradingView
2026.02.07 20:03

Hims & Hers Health 的股價下跌了 14.1%，至 19.76 美元，此前 FDA 限制了其 49 美元減肥藥的銷售，並將該公司移交給司法部以調查可能的違規行為。FDA 警告 Hims & Hers Health 不得將未獲批准的產品稱為已批准藥物的仿製藥，並表示將使用所有執法手段來應對虛假聲明

  • Hims & Hers Health 的股票下跌了 14.1%，至 19.76 美元，此前 FDA 限制了其 49 美元減肥藥的銷售，並將該公司移交給司法部以調查可能的違規行為。1
  • FDA 警告 Hims & Hers Health 不得將未獲批准的產品稱為已批准藥物的仿製藥，表示將使用所有執法工具來處理虛假聲明。2
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.